Prof. Dr. Wilhelm Haverkamp Appointed Chief Medical Officer at SCIRENT
Berlin, 16. April 2026. SCIRENT announced the appointment of Prof. Dr. Wilhelm Haverkamp as Chief Medical Officer (CMO), effective immediately. In this role, Prof. Haverkamp will further strengthen SCIRENT’s medical and scientific leadership and expand the company’s activities in drug safety and clinical oversight. Prof. Haverkamp is an internationally renowned expert in cardiac electrophysiology with […]